Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
15.75    0.00 (0.00%)
Bid:
15.50
Ask:
16.00
Spread: 0.50 (3.226%)
Market Cap: £13.00m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Energy Sector Collaboration

26 Jul 2013 07:00

RNS Number : 1916K
Frontier IP Group plc
26 July 2013
 



 

AIM: FIPP

 

Frontier IP Group Plc

("Frontier IP")

 

Exciting New Energy Sector Collaboration

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce that it has signed an innovative renewable energy sector collaboration with Spanish power group IBERDROLA ("Iberdrola") and renewable energy financial services group Narec Capital Limited ("Narec Capital"). The three parties have signed a memorandum of understanding ("the Memorandum") setting out how they will co-operate to provide investment and industrial leadership for promising clean technology companies.

 

Narec Capital intends to launch its Accelerated Renewable Deployment Portfolio ("ARDP"), with a target fund size of up to £50m that aims to accelerate deployment timeframes and reduce the cost of energy for renewable projects. The Memorandum sets out how Iberdrola will work alongside the ARDP as both a co-investment and industrial partner. Fundraising for the ARDP is underway and both parties are already engaged in assessing and refining a joint deal pipeline.

 

Iberdrola, Spain's leading energy group and one of the world's top power companies with a world leading position in renewable energy, invests in innovative energy technologies and businesses through its corporate venture capital program, PERSEO.

 

Narec Capital provides specialist financial advice to companies and projects within the renewable energy sector. Frontier IP, which is quoted on AIM, specialises in the commercialisation of university intellectual property and has an agreement in place with Narec Capital to provide fund management and administration services to the ARDP.

 

This collaboration brings together financial and industry expertise which will be combined to support investee companies in the energy sector in the development and deployment of their technologies.

 

Jerry Biggs, Chief Executive, Narec Capital said,

 

"There is not only an acute equity gap being experienced by technology companies within this sector but also an obvious adoption gap by the industrial partners who are able to take the technologies through to full operational deployment. The collaboration between our new ARDP fund and Iberdrola Perseo will help to ensure that technologies are selected that have direct application for industry. By applying Narec Capital's rigorous due diligence and commercialisation process alongside Iberdrola's industrial pull through capability, we can help to mitigate risk of failure, address the funding and adoption gap and increase investment returns."

 

Agustín Delgado, Director of Innovation, Environment and Quality, Iberdrola said,

 

"This new partnership will bring us the opportunity to collaborate with two organisations that are a reference in technology development for the renewable sector in the UK. For Iberdrola this is an excellent tool to continue supporting the entrepreneurial ecosystem that is key for addressing the future challenges of the energy sector."

 

Neil Crabb, Chief Executive, Frontier IP said,

 

"This is an exciting partnership and brings together a range of expertise to focus on finding and investing in companies with new technologies in the energy sector. In particular we are interested in renewable electrical energy generation technologies as well as technologies that reduce the environmental impact of existing generation systems. Through our knowledge of the renewable energy sector and experience in raising and managing funds, we hope to play an important part in the success of this new collaboration."

 

 Enquiries

Frontier IP Group Plc

T: 0131 220 9491

Neil Crabb, Chief Executive

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

Mark Percy / Julian Erleigh, Corporate Finance

David Banks / Paul Jewell, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Jon Levinson / Lucy Williams

Biddicks

T: 020 3178 6378

Katie Tzouliadis

 

 

Notes to Editor:

 

Narec Capital is the UK's renewable energy accelerator. The company is a uniquely positioned financial services company with a primary focus on reducing financial risk and providing capital in order to accelerate the deployment and reduce the cost per megawatt hour of renewable energy technologies and projects. www.nareccapital.com 

 

PERSEO is IBERDROLA's corporate venture capital program to invest in the technologies that will help shaping the future of energy. Since its creation in 2008, more than €25M have already been invested through this program in start-up companies around the globe that develop technologies and new businesses in the energy sector.

 

Frontier IP specialises in the commercialisation of Intellectual Property. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities and helps to maximise the commercial value of technologies emerging from their research programmes. www.frontierip.co.uk 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFEEDRIEFIV
Date   Source Headline
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSUnaudited Half Year Results
24th Mar 20257:00 amRNSCamGraphIC secures €25 million in Series A funding
18th Mar 20257:00 amRNS-RPulsiv wins PSMA’s Global Energy Efficiency Award
25th Feb 20257:00 amRNS-RGraphEnergyTech collaboration & Innovate UK grant
18th Feb 20257:00 amRNS-RTopps Tiles launches Alusid’s Mas floor tiles
31st Dec 20241:30 pmRNSTotal Voting Rights
30th Dec 20249:56 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSGrant of Options
19th Dec 20244:14 pmRNSResult of AGM
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20241:36 pmRNSHolding(s) in Company
27th Nov 20247:00 amRNSPosting of Circular & Annual Report, & AGM Notice
26th Nov 20247:00 amRNSResult of Retail Offer
22nd Nov 20241:31 pmRNSResult of Placing and Subscription
22nd Nov 20248:12 amRNSRetail Offer by PrimaryBid
22nd Nov 20247:01 amRNSProposed Placing and Subscription
22nd Nov 20247:00 amRNSFinal results for the year ended 30 June 2024
29th Oct 20244:45 pmRNSHolding(s) in Company
11th Sep 202412:10 pmRNSHolding(s) in Company
7th Aug 20243:52 pmRNSHolding(s) in Company
6th Aug 20243:47 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSPortfolio – Cambridge Raman Imaging loan facility
19th Jun 20247:00 amRNSHolding(s) in Company
24th May 20247:00 amRNSTopps Group’s arm launches Alusid floor tile range
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.